154 related articles for article (PubMed ID: 33539999)
1. Formulation and optimization of sildenafil citrate-loaded PLGA large porous microparticles using spray freeze-drying technique: A factorial design and in-vivo pharmacokinetic study.
Shahin H; Vinjamuri BP; Mahmoud AA; Mansour SM; Chougule MB; Chablani L
Int J Pharm; 2021 Mar; 597():120320. PubMed ID: 33539999
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ).
Almutairi M; Hefnawy A; Almotairy A; Alobaida A; Alyahya M; Althobaiti A; Adel Ali Youssef A; Elkanayati RM; Ashour EA; Smyth HDC; Repka MA
Int J Pharm; 2024 Apr; 655():124044. PubMed ID: 38527563
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic fabrication of inhalable large porous microspheres loaded with H
Zhang H; Hao LZ; Pan JA; Gao Q; Zhang JF; Kankala RK; Wang SB; Chen AZ; Zhang HL
J Control Release; 2021 Jan; 329():286-298. PubMed ID: 33279605
[TBL] [Abstract][Full Text] [Related]
5. Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics
Ghasemian E; Vatanara A; Rouini MR; Rouholamini Najafabadi A; Gilani K; Lavasani H; Mohajel N
Pharm Dev Technol; 2016 Dec; 21(8):961-971. PubMed ID: 26428267
[TBL] [Abstract][Full Text] [Related]
6. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
7. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
Rashid J; Patel B; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
J Control Release; 2017 Mar; 250():96-106. PubMed ID: 28185800
[TBL] [Abstract][Full Text] [Related]
8. Systemic delivery of parathyroid hormone (1-34) using spray freeze-dried inhalable particles.
Poursina N; Vatanara A; Rouini MR; Gilani K; Rouholamini Najafabadi A
Pharm Dev Technol; 2017 Sep; 22(6):733-739. PubMed ID: 26708720
[TBL] [Abstract][Full Text] [Related]
9. Formulation and process considerations for the design of sildenafil-loaded polymeric microparticles by vibrational spray-drying.
Beck-Broichsitter M; Bohr A; Aragão-Santiago L; Klingl A; Kissel T
Pharm Dev Technol; 2017 Sep; 22(6):691-698. PubMed ID: 26740242
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil.
Nguyen TT; Yi EJ; Hwang KM; Cho CH; Park CW; Kim JY; Rhee YS; Park ES
Drug Deliv Transl Res; 2019 Feb; 9(1):319-333. PubMed ID: 30276666
[TBL] [Abstract][Full Text] [Related]
11. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
12. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.
Varshosaz J; Taymouri S; Hamishehkar H; Vatankhah R; Yaghubi S
Res Pharm Sci; 2017 Jun; 12(3):222-232. PubMed ID: 28626480
[TBL] [Abstract][Full Text] [Related]
13. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Delivery of Docetaxel and Celecoxib by PLGA Porous Microparticles for Their Synergistic Effects Against Lung Cancer.
Ziaei E; Emami J; Rezazadeh M; Kazemi M
Anticancer Agents Med Chem; 2022; 22(5):951-967. PubMed ID: 34382530
[TBL] [Abstract][Full Text] [Related]
15. Large porous particles for respiratory drug delivery. Glycine-based formulations.
Ogienko AG; Bogdanova EG; Trofimov NA; Myz SA; Ogienko AA; Kolesov BA; Yunoshev AS; Zubikov NV; Manakov AY; Boldyrev VV; Boldyreva EV
Eur J Pharm Sci; 2017 Dec; 110():148-156. PubMed ID: 28479348
[TBL] [Abstract][Full Text] [Related]
16. Inhalable oridonin-loaded poly(lactic-
Zhu L; Li M; Liu X; Du L; Jin Y
Acta Pharm Sin B; 2017 Jan; 7(1):80-90. PubMed ID: 28119812
[TBL] [Abstract][Full Text] [Related]
17. Inhaled bosentan microparticles for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.
Lee HJ; Kwon YB; Kang JH; Oh DW; Park ES; Rhee YS; Kim JY; Shin DH; Kim DW; Park CW
J Control Release; 2021 Jan; 329():468-481. PubMed ID: 32871206
[TBL] [Abstract][Full Text] [Related]
18. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation.
Amaro MI; Tewes F; Gobbo O; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
Int J Pharm; 2015 Apr; 483(1-2):6-18. PubMed ID: 25660067
[TBL] [Abstract][Full Text] [Related]
19. Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment.
Teymouri Rad R; Dadashzadeh S; Vatanara A; Alavi S; Ghasemian E; Mortazavi SA
Eur J Pharm Sci; 2019 May; 133():275-286. PubMed ID: 30953751
[TBL] [Abstract][Full Text] [Related]
20. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
